| Mon, Nov 2, 2009 | | | Amylin Makes Obesity Drug Deal: BioBuzz at TheStreet.com (Mon, Nov 2)
| | | Amylin Strikes First With Obesity Drug Deal at TheStreet.com (Mon, Nov 2)
| | | Amylin Strikes First With Obesity Drug Deal: BioBuzz at TheStreet.com (Mon, Nov 2)
| | Fri, Oct 30, 2009 | | | ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online (Fri, Oct 30)
| | | Friday At The Fat Fight at CNBC (Fri, Oct 30)
| | Wed, Oct 28, 2009 | | | Vivus, Analyst in Obesity Drug Side-Effect Spat at TheStreet.com (Wed, Oct 28)
| | Tue, Oct 27, 2009 | | | New Data From Arena Pharmaceuticals' Pivotal BLOSSOM Trial of Lorcaserin Demonstrate Improvements in Patients' Body Composition, Cardiovascular Risk Factors and Quality of Life PR Newswire (Tue, Oct 27)
| | Mon, Oct 26, 2009 | | | Phase III Trial Expenses For Diabetes Treatments Now Forcing Acquisitions Of Small Cap Biotech Firms: FDA Has "Raised The Bar" For Approval Due To Recent Cardiovascular Issues Wall Street Transcript (Mon, Oct 26)
| | | Sector Snap: Obesity drug makers gain ground AP (Mon, Oct 26)
| | | Vivus' Mr. Wilson Goes To Washington at CNBC (Mon, Oct 26)
| | | [video] Saving Health Care Dollars...and Lives at CNBC (Mon, Oct 26)
| | | [video] The Battle Against Obesity at CNBC (Mon, Oct 26)
| | | Arena Pharma rises on new lorcaserin trial data AP (Mon, Oct 26)
| | | [video] Trimming the Health Care Fat at CNBC (Mon, Oct 26)
| | | Early Movers: Pump Up the Volume at TheStreet.com (Mon, Oct 26)
| | Sun, Oct 25, 2009 | | | Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation PR Newswire (Sun, Oct 25)
| | Thu, Oct 22, 2009 | | | Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences PR Newswire (Thu, Oct 22)
| | Wed, Oct 21, 2009 | | | ARENA PHARMACEUTICALS INC Files SEC form 8-K/A, Financial Statements and Exhibits EDGAR Online (Wed, Oct 21)
| | Sat, Oct 17, 2009 | | | Medicine's Elusive Goal: A Safe Weight-Loss Drug at The New York Times (Sat, Oct 17)
| | | Assessing the Chances for the Next Wave of Obesity Drugs at The New York Times (Sat, Oct 17)
| | Mon, Oct 12, 2009 | | | 4-Star Stocks on the Upswing at Motley Fool (Mon, Oct 12)
| | | Arena Pharmaceuticals' Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 PR Newswire (Mon, Oct 12)
| | Fri, Oct 9, 2009 | | | Biotech Mailbag: Transdel Pharma at TheStreet.com (Fri, Oct 9)
| | Thu, Oct 8, 2009 | | | 3 Stocks in a Tailspin at Motley Fool (Thu, Oct 8)
| | Mon, Oct 5, 2009 | | | Tomorrow's Monster Stock? at Motley Fool (Mon, Oct 5)
| Add ARNA News to My Yahoo!:

| |
|